Press Releases June 26, 2026 07:00 AM

Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026

Balchem Corporation to Present at CJS Securities 26th Annual New Ideas Summer Conference in July 2026

By Jordan Park
Share
Twitter Reddit Facebook LinkedIn
BCPC

Balchem Corporation, a global specialty ingredient manufacturer serving health and nutrition markets, announced it will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Key executives including the CEO, CFO, and Senior Director of Investor Relations will represent the company at the event.

Balchem Corporation to Participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026
BCPC
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Balchem Corporation is a global manufacturer specializing in ingredients for health and nutrition sectors.
  • The company operates three main business segments: Human Nutrition & Health, Animal Nutrition & Health, and Specialty Products.
  • Senior leadership will participate in the upcoming investor conference, providing opportunities for investor engagement and corporate updates.

MONTVALE, N.J., June 26, 2026 (GLOBE NEWSWIRE) -- Balchem Corporation (NASDAQ: BCPC), a global specialty ingredient manufacturer for health and nutrition markets, announced they will participate in the CJS Securities 26th Annual New Ideas Summer Conference on July 9, 2026. Ted Harris, Chairman of the Board, President and Chief Executive Officer, Martin Bengtsson, Chief Financial Officer and Allison Baurichter, Senior Director Investor Relations will participate in the conference.

About Balchem Corporation

Balchem Corporation develops, manufactures and markets specialty ingredients that improve and enhance the health and well-being of life on the planet, providing state-of-the-art solutions and the finest quality products for a range of industries worldwide. The company reports three business segments: Human Nutrition & Health; Animal Nutrition & Health; and Specialty Products. The Human Nutrition & Health segment delivers customized food and beverage ingredient systems, as well as key nutrients into a variety of applications across the food, supplement and pharmaceutical industries. The Animal Nutrition & Health segment manufactures and supplies products to numerous animal health markets. Through Specialty Products, Balchem provides specialty-packaged chemicals for use in healthcare and other industries, and also provides chelated minerals to the micronutrient agricultural market.

Contact: Jacqueline Yarmolowicz
Balchem Corporation (Telephone: 845-326-5600)

Risks

  • The press release does not disclose any new financial results or business developments, limiting immediate impact on investor sentiment.
  • Market reaction may depend on the content and disclosures made during the conference, which remain unknown.
  • The company's performance is tied to global health, nutrition, pharmaceutical, agricultural, and specialty chemical markets, which can be affected by economic and regulatory factors.

More from Press Releases

ArcelorMittal publishes its 2025 Payments to Governments in respect of extractive activities report Jun 26, 2026 Opus Genetics Added to the Russell 3000®, Russell 2000® and Russell Microcap® Indexes Jun 26, 2026 SaverOne and VisionWave Complete Their Strategic Transaction to Advance an RF Defense Platform Jun 26, 2026 Capricor to Present Positive Five-Year HOPE-2 OLE Data and HOPE-3 Phase 3 Results for Deramiocel in Duchenne Muscular Dystrophy at PPMD 2026 Annual Conference Jun 26, 2026 SB Financial Group, Inc. Announces Schedule for Second Quarter 2026 Results Jun 26, 2026